Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,886.24
(
1.02%
)
US TECH 100
24,753.20
(
1.27%
)
Dow Jones
48,218.25
(
0.63%
)
Brent Oil
95.31
(
-0.17%
)
Bitcoin
74,338.27
(
-0.22%
)
News Focus
News Focus
Post# of 257403
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Biopharm investor

Send PM Follow Ignore
Followers 6
Posts 166
Boards Moderated 0
Alias Born 06/25/2004

Biopharm investor

Re: DewDiligence post# 3442

Tuesday, 08/31/2004 8:05:56 AM

Tuesday, August 31, 2004 8:05:56 AM

Post# of 257403
Loopholes

I don't agree that the FTF status is a "loophole".

I think a bigger issue is the parking of exclusivity that comes with FTF status. This prevents the opening of a market for a given drug, costing consumers millions.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today